The vocabulary gap in St. Louis exam rooms, explained

In a St. Louis exam room, a patient says, "I just need some help with the depression. Nothing is working." The physician hears a history of failed trials, a possible candidate for a different approach, maybe a referral. The patient means something simpler: I am tired, and I do not know what else exists.

Both are describing the same situation in two different languages. This explainer, meant for St. Louis-area primary care physicians and anyone else who refers, looks at that gap, why it exists, and how to bridge it. Its numbers come from our 443-person survey spanning ten Midwest states, both Missouri and Illinois included. The numbers describe the whole sample, as validated in the final data.

Two vocabularies

Clinical language is precise by design. Treatment-resistant depression. Augmentation. Esketamine. Transcranial magnetic stimulation. These terms let clinicians communicate exactly.

Patient language is precise in a different way. It describes experience. Given a blank box for the words they would search in a rough stretch, 319 respondents filled it in. "Ptsd treatments" and "therapist near me" were typical. One wrote only "depressed." Another wrote "someone please help me."

Nothing we quote from them names a drug. Patients describe the problem and ask for help. They leave the solution blank, which is, in effect, a request for you to fill it in.

Why the gap exists

The main reason is awareness. Spravato, an esketamine spray carrying FDA approval in treatment-resistant depression, drew no recognition from 73 percent of our respondents, and 21 percent more recognized the word alone, while 6 percent could explain it.

A second reason is that patients are not trying to diagnose themselves. They are trying to be understood. "Nothing is working" is a complete thought to them. They are waiting for someone with the vocabulary to take the next step.

The survey confirms who they expect that someone to be. Fifty-six percent would take a newer-treatment question to primary care before anyone else. Their own doctor's recommendation would sway 74 percent the most, against 2 percent for ads.

Decoding common phrases

Each kind of patient phrase can prompt a useful follow-up question.

• "Nothing is working" or "help with depression." Ask which medications, what doses, for how long, and what happened. This establishes whether prior trials were adequate, which matters for any referral onward.
• "Are there alternatives to these medicines?" This echoes one respondent's search, "depression medicine alternatives." It may reflect side effects, a sense of stalled progress, or a preference for non-drug approaches. Sixty-four percent of respondents told us drug-free options mattered.
• "My husband has been searching how to help me." A caregiver is involved. "How to help someone with depression" was one respondent's search. Family members often hold history the patient omits and may be the one driving to appointments.
• "I have PTSD too." Several respondents typed PTSD searches. Trauma may shape which clinic fits and how the patient feels about certain settings.
• "I just need someone to help me." Treat this as a cue for a safety assessment before any referral conversation.

Bridging the gap in the St. Louis region

The St. Louis area adds a few practical wrinkles to any referral.

• Two states, two Medicaid programs. The region spans Missouri and the Illinois Metro East. A patient on MO HealthNet and a patient on Illinois Medicaid may face different plans, networks, and prior authorization rules, even if the clinic is just across the river. Confirm which state's plans a clinic accepts.
• Payer mix is broad. In the survey, commercial coverage (39 percent) and Medicaid (37 percent) were reported at almost identical rates, and Medicare followed at 23 percent. Any referral list built around one payer type will not serve the whole panel.
• Distance is not trivial. The metro stretches from the Metro East to St. Charles County and out toward Franklin and Jefferson counties. Close to home was a top-two provider factor for 43 percent of respondents. Esketamine requires a supervised wait after every dose, plus a ride home, with frequent visits early on, so a clinic's location can decide whether treatment starts.

Language that works

When you introduce an option, give patients words they can hold onto. A pattern that tends to land:

"For depression that regular antidepressants have not budged, the FDA has approved a nasal spray called Spravato. Each dose is taken at a certified clinic, and someone would need to drive you home afterward. Let's see whether it makes sense for you, and whether your insurance covers it."

That sentence moves from what it is, to what it is called, to what it involves, to the practical question patients care about most. Coverage made the top-two lists of 85 percent of respondents, more than anything else. For patients who want to read more after the visit, this Spravato overview uses plain terms.

It also helps to draw a clear line between the approved product and what patients may find online. IV ketamine clinics use ketamine off-label, and at-home ketamine services operate without a clinician present during use. Patients who search after your visit will encounter all three.

What patients bring emotionally

Respondents' first reactions to ketamine therapy suggest the room is more open than closed. About a third said cautious but open. The rest spread across skeptical at 21 percent, hopeful or curious at 18, unfamiliar at another 18, and negative at 9 percent. Plain, honest explanation serves all of these groups better than enthusiasm.

Scope

This is research into how patients talk and choose care; it is neither clinical evidence nor practice guidance. Whether a patient is a candidate for any treatment is a clinical decision.

For patients in distress, on both sides of the river, the Suicide and Crisis Lifeline answers 988 at any hour, whether you call or text; veterans can press 1.

Methodology

Pollfish fielded the survey on its consumer panel, and by the June 23, 2026 close it had heard from 443 adults. Each was 18 to 64, living in Missouri, Illinois, Kansas, Iowa, Oklahoma, Nebraska, Ohio, Indiana, Minnesota, and Wisconsin. We cite ten-state top-line results here rather than metro figures, all from the validated final dataset. Search phrases are from 319 open responses. The research was commissioned and funded by the publisher.